| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 108.31 mm | 108.31 mm | 108.31 mm | 108.31 mm | 108.31 mm | 108.31 mm |
| Cash burn (monthly) | 18.72 mm | 24.22 mm | 17.72 mm | 11.46 mm | 15.34 mm | 6.96 mm |
| Cash used (since last report) | 42.76 mm | 55.31 mm | 40.47 mm | 26.19 mm | 35.05 mm | 15.89 mm |
| Cash remaining | 65.54 mm | 52.99 mm | 67.84 mm | 82.12 mm | 73.26 mm | 92.42 mm |
| Runway (months of cash) | 3.5 | 2.2 | 3.8 | 7.2 | 4.8 | 13.3 |
| 13F holders | Current |
|---|---|
| Total holders | 213 |
| Opened positions | 48 |
| Closed positions | 25 |
| Increased positions | 72 |
| Reduced positions | 56 |
| 13F shares | Current |
|---|---|
| Total value | 4.14 tn |
| Total shares | 64.20 mm |
| Total puts | 432.80 k |
| Total calls | 433.50 k |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 7.96 mm | $610.19 bn |
| GILD Gilead Sciences | 6.72 mm | $515.42 bn |
| Paradigm Biocapital Advisors | 4.37 mm | $335.26 bn |
| BlackRock | 3.85 mm | $295.56 bn |
| NEA Management | 3.75 mm | $287.22 bn |
| New Enterprise Associates 15 | 3.75 mm | $165.99 mm |
| Perceptive Advisors | 3.48 mm | $266.80 bn |
| Vanguard | 3.33 mm | $255.38 bn |
| Ra Capital Management | 2.79 mm | $213.76 bn |
| SR One Capital Management | 2.35 mm | $169.05 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Feb 25 | Rami Elghandour | Common Stock | Grant | Acquire A | No | No | 0 | 347,255 | 0.00 | 1,164,857 |
| 27 Feb 25 | Rami Elghandour | Common Stock | Grant | Acquire A | No | No | 0 | 668,416 | 0.00 | 817,602 |
| 26 Feb 25 | Rami Elghandour | Common Stock | Sell | Dispose S | No | No | 62.6894 | 10,889 | 682.62 k | 149,186 |
| 26 Feb 25 | Rami Elghandour | Common Stock | Sell | Dispose S | No | No | 61.9464 | 21,077 | 1.31 mm | 160,075 |
| 26 Feb 25 | Rami Elghandour | Common Stock | Sell | Dispose S | No | No | 61.138 | 6,334 | 387.25 k | 181,152 |
| 25 Feb 25 | Kavita Patel | Common Stock | Sell | Dispose S | No | Yes | 63.16 | 1,500 | 94.74 k | 0 |
| 25 Feb 25 | Kavita Patel | Common Stock | Option exercise | Acquire M | No | No | 6.66 | 1,500 | 9.99 k | 1,500 |
| 25 Feb 25 | Kavita Patel | Stock Option Common Stock | Option exercise | Dispose M | No | No | 6.66 | 1,500 | 9.99 k | 34,577 |
| 24 Feb 25 | Heery Christopher | Common Stock | Sell | Dispose S | No | No | 64.8778 | 208 | 13.49 k | 37,486 |
| 24 Feb 25 | Heery Christopher | Common Stock | Sell | Dispose S | No | No | 64.2568 | 5,577 | 358.36 k | 37,694 |
